title: Can treatment of chronic inflammatory diseases reduce the risk of diabetes mellitus?
authors.forename: Tim
authors.initials: T
authors.lastname: Bongartz
authors.forename: Yogish
authors.initials: Y
authors.lastname: Kudva
mesh_terms: D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D003924:Diabetes Mellitus, Type 2 / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D006886:Hydroxychloroquine / Q000494:pharmacology* / Q000627:therapeutic use; D007249:Inflammation / Q000150:complications / Q000188:drug therapy*; D011565:Psoriasis / Q000188:drug therapy; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D000893:Anti-Inflammatory Agents; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D006886:Hydroxychloroquine